Chromatography could be a valuable tool notably within the pharmaceutical and biotechnology sectors because it will give sensitive info concerning product quality and purity. The implementation of method analytical technology has conjointly given a lift to the current market. The growing demands of biopharmaceuticals, notably being antibodies, biosimilar medicine et al. have conjointly necessitated biotechnology and biopharmaceutical industries to take a position in high-throughput bioprocessing and downstream process instruments. The advances in technology for the event of improved systems, innovative and disposable columns, better-performing resins, and alternative accessories square measure serving to this market to grow considerably.
Market Insights
The global Chromatography in Pharmaceuticals and Biotechnology market is segregated on the basis of Technology Type as Product, Instruments, Technology, and Reagents. Based on Types the global Chromatography in Pharmaceuticals and Biotechnology market is segmented in Gas Chromatography, Thin Layer Chromatography, Supercritical Fluid Chromatography, Liquid Chromatography, High-Performance Liquid Chromatography/Ultra High-Performance Liquid Chromatography (HPLC/UHPLC), and Affinity Chromatography. Based on End-User Industry the global Chromatography in Pharmaceuticals and Biotechnology market is segmented in Cancer Research Centers, Cancer Hospital, Pharmaceutical., Pathological Sectors, and Companies and Academic Institutions.
Based on Application, the global Chromatography in Pharmaceuticals and Biotechnology market is segmented in Drug Discovery and Development, Downstream Processing, Proteomics, Diagnostics, Pharmaceutical Analysis, Metabolomics.
The global Chromatography in Pharmaceuticals and Biotechnology market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Chromatography in Pharmaceuticals and Biotechnology market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Novasep Inc., Perkinelmer, Inc., Scion Instruments, Ge Healthcare Life Sciences, Chiral Technologies Inc., Hamilton Co., Hichrom Ltd., Antec Scientific, Asynt Ltd., Bio-Lab Ltd., and others are among the major players in the global Chromatography in Pharmaceuticals and Biotechnology market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Chromatography in Pharmaceuticals and Biotechnology Market has been segmented as below:
Chromatography in Pharmaceuticals and Biotechnology Market, By Technology Type
Chromatography in Pharmaceuticals and Biotechnology Market, By Types
Chromatography in Pharmaceuticals and Biotechnology Market, By End-User Industry
Chromatography in Pharmaceuticals and Biotechnology Market, By Application
Chromatography in Pharmaceuticals and Biotechnology Market, By Region
Chromatography in Pharmaceuticals and Biotechnology Market, By Company
The report covers:
Report Scope:
The global Chromatography in Pharmaceuticals and Biotechnology market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Chromatography in Pharmaceuticals and Biotechnology market share. Major industry players with significant revenue share include Novasep Inc., Perkinelmer, Inc., Scion Instruments, Ge Healthcare Life Sciences, Chiral Technologies Inc., Hamilton Co., Hichrom Ltd., Antec Scientific, Asynt Ltd., Bio-Lab Ltd., and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations.
Below are our New Reports :-
Cell Separation and Characterization in Solid Tumors market
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach – Segmental Market Analysis
2.5.2 Top-Down Approach – Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter’s Five Force Analysis
5. Chromatography in Pharmaceuticals and Biotechnology Market, By Technology Type
5.1 Introduction
5.2 Product
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Instruments
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Technology
5.4.1 Market Overview
5.4.2 Market Size and Forecast
5.5 Reagents
5.5.1 Market Overview
5.5.2 Market Size and Forecast
6. Chromatography in Pharmaceuticals and Biotechnology Market, By Types
6.1 Introduction
6.2 Gas Chromatography
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Thin Layer Chromatography
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Supercritical Fluid Chromatography
6.4.1 Market Overview
6.4.2 Market Size and Forecast
6.5 Liquid Chromatography
6.5.1 Market Overview
6.5.2 Market Size and Forecast
6.6 High-Performance Liquid Chromatography/Ultra High-Performance Liquid Chromatography (HPLC/UHPLC)
6.6.1 Market Overview
6.6.2 Market Size and Forecast
6.7 Affinity Chromatography
6.7.1 Market Overview
6.7.2 Market Size and Forecast
7. Chromatography in Pharmaceuticals and Biotechnology Market, By End-User Industry
7.1 Introduction
7.2 Cancer Research Centers
7.2.1 Market Overview
7.2.2 Market Size and Forecast
7.3 Cancer Hospital
7.3.1 Market Overview
7.3.2 Market Size and Forecast
7.4 Pharmaceutical.
7.4.1 Market Overview
7.4.2 Market Size and Forecast
7.5 Pathological Sectors,
7.5.1 Market Overview
7.5.2 Market Size and Forecast
7.6 Companies and Academic Institutions
7.6.1 Market Overview
7.6.2 Market Size and Forecast
8. Chromatography in Pharmaceuticals and Biotechnology Market, By Application
8.1 Introduction
8.2 Drug Discovery and Development
8.2.1 Market Overview
8.2.2 Market Size and Forecast
8.3 Downstream Processing
8.3.1 Market Overview
8.3.2 Market Size and Forecast
8.4 Proteomics
8.4.1 Market Overview
8.4.2 Market Size and Forecast
8.5 Diagnostics
8.5.1 Market Overview
8.5.2 Market Size and Forecast
8.6 Pharmaceutical Analysis
8.6.1 Market Overview
8.6.2 Market Size and Forecast
8.7 Metabolomics
8.7.1 Market Overview
8.7.2 Market Size and Forecast
8.8 Application B8
8.8.1 Market Overview
8.8.2 Market Size and Forecast
8.9 Application B10
8.9.1 Market Overview
8.9.2 Market Size and Forecast
8.10 Application B10
8.10.1 Market Overview
8.10.2 Market Size and Forecast
8.11 Application B10
8.11.1 Market Overview
8.11.2 Market Size and Forecast
9. Chromatography in Pharmaceuticals and Biotechnology Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 North America Chromatography in Pharmaceuticals and Biotechnology, By Technology Type
9.2.2 North America Chromatography in Pharmaceuticals and Biotechnology, By Types
9.2.3 North America Chromatography in Pharmaceuticals and Biotechnology, By End-User Industry
9.2.4 North America Chromatography in Pharmaceuticals and Biotechnology, By Application
9.3 Europe
9.3.1 Europe Chromatography in Pharmaceuticals and Biotechnology, By Technology Type
9.3.2 Europe Chromatography in Pharmaceuticals and Biotechnology, By Types
9.3.3 Europe Chromatography in Pharmaceuticals and Biotechnology, By End-User Industry
9.3.4 Europe Chromatography in Pharmaceuticals and Biotechnology, By Application
9.4 Asia-Pacific
9.4.1 Asia-Pacific Chromatography in Pharmaceuticals and Biotechnology, By Technology Type
9.4.2 Asia-Pacific Chromatography in Pharmaceuticals and Biotechnology, By Types
9.4.3 Asia-Pacific Chromatography in Pharmaceuticals and Biotechnology, By End-User Industry
9.4.4 Asia-Pacific Chromatography in Pharmaceuticals and Biotechnology, By Application
9.5 Rest of the World
9.5.1 Rest of the World Chromatography in Pharmaceuticals and Biotechnology, By Technology Type
9.5.2 Rest of the World Chromatography in Pharmaceuticals and Biotechnology, By Types
9.5.3 Rest of the World Chromatography in Pharmaceuticals and Biotechnology, By End-User Industry
9.5.4 Rest of the World Chromatography in Pharmaceuticals and Biotechnology, By Application
10. Competitive Insights
10.1 Key Insights
10.2 Company Market Share Analysis
10.3 Strategic Outlook
10.3.1 Mergers & Acquisitions
10.3.2 New Product Development
10.3.3 Portfolio/Production Capacity Expansions
10.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
10.3.5 Others
11. Company Profiles
11.1 Novasep Inc.
11.1.1 Company Overview
11.1.2 Product/Service Landscape
11.1.3 Financial Overview
11.1.4 Recent Developments
11.2 Perkinelmer, Inc.
11.2.1 Company Overview
11.2.2 Product/Service Landscape
11.2.3 Financial Overview
11.2.4 Recent Developments
11.3 Scion Instruments
11.3.1 Company Overview
11.3.2 Product/Service Landscape
11.3.3 Financial Overview
11.3.4 Recent Developments
11.4 Ge Healthcare Life Sciences
11.4.1 Company Overview
11.4.2 Product/Service Landscape
11.4.3 Financial Overview
11.4.4 Recent Developments
11.5 Chiral Technologies Inc.
11.5.1 Company Overview
11.5.2 Product/Service Landscape
11.5.3 Financial Overview
11.5.4 Recent Developments
11.6 Hamilton Co.
11.6.1 Company Overview
11.6.2 Product/Service Landscape
11.6.3 Financial Overview
11.6.4 Recent Developments
11.7 Hichrom Ltd.
11.7.1 Company Overview
11.7.2 Product/Service Landscape
11.7.3 Financial Overview
11.7.4 Recent Developments
11.8 Antec Scientific
11.8.1 Company Overview
11.8.2 Product/Service Landscape
11.8.3 Financial Overview
11.8.4 Recent Developments
11.9 Asynt Ltd.
11.9.1 Company Overview
11.9.2 Product/Service Landscape
11.9.3 Financial Overview
11.9.4 Recent Developments
11.10 Bio-Lab Ltd.
11.10.1 Company Overview
11.10.2 Product/Service Landscape
11.10.3 Financial Overview
11.10.4 Recent Developments
The Chromatography in Pharmaceuticals and Biotechnology Market has been segmented as below:
Chromatography in Pharmaceuticals and Biotechnology Market, By Technology Type
Chromatography in Pharmaceuticals and Biotechnology Market, By Types
Chromatography in Pharmaceuticals and Biotechnology Market, By End-User Industry
Chromatography in Pharmaceuticals and Biotechnology Market, By Application
Chromatography in Pharmaceuticals and Biotechnology Market, By Region
Chromatography in Pharmaceuticals and Biotechnology Market, By Company
